Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Sarcoma 3Head & Neck 2Gynecologic 2Dermatologic 2Plasma cell 1Genitourinary 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Head and Neck Neoplasms 1Carcinoma, Adenoid Cystic 1

Interventions

Cisplatin 315Radiotherapy 139Cetuximab 133pembrolizumab 131Docetaxel 122Carboplatin 119Radiotherapy, Intensity-Modulated 97Fluorouracil 94Paclitaxel 92Nivolumab 64Gemcitabine 50toripalimab 46Radiation 44Drug Therapy 39Capecitabine 39Magnetic Resonance Spectroscopy 38Surgical Procedures, Operative 33camrelizumab 31130-nm albumin-bound paclitaxel 29apatinib 27tislelizumab 26Chemoradiotherapy 26Specimen Handling 25Bevacizumab 24durvalumab 23Albumin-Bound Paclitaxel 23nimotuzumab 22lenvatinib 21Sorafenib 21Platinum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Nelfinavir × Head & Neck × Clear all
NCT02207439 2023-07-25

Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
18 enrolled 9 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01065844 2019-10-09

Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck

University of Iowa

Phase 2 Completed
15 enrolled 3 charts
Head & Neck

Carcinoma, Adenoid Cystic, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡